Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen?
Mycoplasma amphoriforme is a recently described organism isolated from the respiratory tracts of patients with immunodeficiency and evidence of chronic infection. Novel assays for the molecular detection of the organism by real-time quantitative PCRs (qPCRs) targeting the uracil DNA glycosylase gene...
Saved in:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.34852 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.348522018-11-09T10:05:20Z Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? Clare L. Ling Katarina Oravcova Thomas F. Beattie Dean D. Creer Paul Dilworth Naomi L. Fulton Alison Hardie Michelle Munro Marcus Pond Kate Templeton David Webster Sarita Workman Timothy D. McHugh Stephen H. Gillespie UCL University of St Andrews, School of Medicine Royal Hospital for Sick Children Barnet General Hospital UCL Medical School Royal Infirmary of Edinburgh Health Protection Agency NHS Foundation Trust Mahidol University Medicine Mycoplasma amphoriforme is a recently described organism isolated from the respiratory tracts of patients with immunodeficiency and evidence of chronic infection. Novel assays for the molecular detection of the organism by real-time quantitative PCRs (qPCRs) targeting the uracil DNA glycosylase gene ( udg) or the 23S rRNA gene are described here. The analytical sensitivities are similar to the existing conventional M. amphoriforme 16S rRNA gene PCR, with the advantage of being species specific, rapid, and quantitative. By using these techniques, we demonstrate the presence of this organism in 17 (19.3%) primary anti-body-deficient (PAD) patients, 4 (5%) adults with lower respiratory tract infection, 1 (2.6%) sputum sample from a patient attending a chest clinic, and 23 (0.21%) samples submitted for viral diagnosis of respiratory infection, but not in normal adult control subjects. These data show the presence of this microorganism in respiratory patients and suggest that M. amphoriforme may infect both immunocompetent and immunocompromised people. Further studies to characterize this organism are required, and this report provides the tools that may be used by other research groups to investigate its pathogenic potential. Copyright © 2014 American Society for Microbiology. All Rights Reserved. 2018-11-09T03:05:20Z 2018-11-09T03:05:20Z 2014-01-01 Article Journal of Clinical Microbiology. Vol.52, No.4 (2014), 1177-1181 10.1128/JCM.03049-13 1098660X 00951137 2-s2.0-84897145728 https://repository.li.mahidol.ac.th/handle/123456789/34852 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897145728&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Clare L. Ling Katarina Oravcova Thomas F. Beattie Dean D. Creer Paul Dilworth Naomi L. Fulton Alison Hardie Michelle Munro Marcus Pond Kate Templeton David Webster Sarita Workman Timothy D. McHugh Stephen H. Gillespie Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
description |
Mycoplasma amphoriforme is a recently described organism isolated from the respiratory tracts of patients with immunodeficiency and evidence of chronic infection. Novel assays for the molecular detection of the organism by real-time quantitative PCRs (qPCRs) targeting the uracil DNA glycosylase gene ( udg) or the 23S rRNA gene are described here. The analytical sensitivities are similar to the existing conventional M. amphoriforme 16S rRNA gene PCR, with the advantage of being species specific, rapid, and quantitative. By using these techniques, we demonstrate the presence of this organism in 17 (19.3%) primary anti-body-deficient (PAD) patients, 4 (5%) adults with lower respiratory tract infection, 1 (2.6%) sputum sample from a patient attending a chest clinic, and 23 (0.21%) samples submitted for viral diagnosis of respiratory infection, but not in normal adult control subjects. These data show the presence of this microorganism in respiratory patients and suggest that M. amphoriforme may infect both immunocompetent and immunocompromised people. Further studies to characterize this organism are required, and this report provides the tools that may be used by other research groups to investigate its pathogenic potential. Copyright © 2014 American Society for Microbiology. All Rights Reserved. |
author2 |
UCL |
author_facet |
UCL Clare L. Ling Katarina Oravcova Thomas F. Beattie Dean D. Creer Paul Dilworth Naomi L. Fulton Alison Hardie Michelle Munro Marcus Pond Kate Templeton David Webster Sarita Workman Timothy D. McHugh Stephen H. Gillespie |
format |
Article |
author |
Clare L. Ling Katarina Oravcova Thomas F. Beattie Dean D. Creer Paul Dilworth Naomi L. Fulton Alison Hardie Michelle Munro Marcus Pond Kate Templeton David Webster Sarita Workman Timothy D. McHugh Stephen H. Gillespie |
author_sort |
Clare L. Ling |
title |
Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
title_short |
Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
title_full |
Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
title_fullStr |
Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
title_full_unstemmed |
Tools for detection of Mycoplasma amphoriforme: A primary respiratory pathogen? |
title_sort |
tools for detection of mycoplasma amphoriforme: a primary respiratory pathogen? |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/34852 |
_version_ |
1763494088935473152 |